{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:48:35Z","timestamp":1792648115348,"version":"4.5.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T00:00:00Z","timestamp":1340755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1479-5876-10-134","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T18:49:34Z","timestamp":1340822974000},"source":"Crossref","is-referenced-by-count":361,"title":["Exosome removal as a therapeutic adjuvant in cancer"],"prefix":"10.1186","volume":"10","author":[{"given":"Annette M","family":"Marleau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Shing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H","family":"Tullis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,27]]},"reference":[{"key":"1091_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2005.07.008","volume":"16","author":"TL Whiteside","year":"2006","unstructured":"Whiteside TL: Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. Semin Cancer Biol. 2006, 16: 3-15. 10.1016\/j.semcancer.2005.07.008.","journal-title":"Semin Cancer Biol"},{"key":"1091_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.imlet.2006.09.005","volume":"107","author":"S Keller","year":"2006","unstructured":"Keller S, Sanderson MP, Stoeck A, Altevogt P: Exosomes: from biogenesis and secretion to biological function. Immunol Lett. 2006, 107: 102-108. 10.1016\/j.imlet.2006.09.005.","journal-title":"Immunol Lett"},{"key":"1091_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ceb.2004.06.003","volume":"16","author":"B Fevrier","year":"2004","unstructured":"Fevrier B, Raposo G: Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol. 2004, 16: 415-421. 10.1016\/j.ceb.2004.06.003.","journal-title":"Curr Opin Cell Biol"},{"key":"1091_CR4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1600-0854.2004.00223.x","volume":"5","author":"A de Gassart","year":"2004","unstructured":"de Gassart A, Geminard C, Hoekstra D, Vidal M: Exosome secretion: the art of reutilizing nonrecycled proteins?. Traffic. 2004, 5: 896-903. 10.1111\/j.1600-0854.2004.00223.x.","journal-title":"Traffic"},{"key":"1091_CR5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","volume":"2","author":"C Thery","year":"2002","unstructured":"Thery C, Zitvogel L, Amigorena S: Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002, 2: 569-579.","journal-title":"Nat Rev Immunol"},{"key":"1091_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1034\/j.1600-0854.2002.30502.x","volume":"3","author":"W Stoorvogel","year":"2002","unstructured":"Stoorvogel W, Kleijmeer MJ, Geuze HJ, Raposo G: The biogenesis and functions of exosomes. Traffic. 2002, 3: 321-330. 10.1034\/j.1600-0854.2002.30502.x.","journal-title":"Traffic"},{"key":"1091_CR7","doi-asserted-by":"publisher","first-page":"34211","DOI":"10.1074\/jbc.M109.041152","volume":"284","author":"I Parolini","year":"2009","unstructured":"Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, Coscia C, Iessi E, Logozzi M, Molinari A: Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem. 2009, 284: 34211-34222. 10.1074\/jbc.M109.041152.","journal-title":"J Biol Chem"},{"key":"1091_CR8","doi-asserted-by":"publisher","first-page":"e24234","DOI":"10.1371\/journal.pone.0024234","volume":"6","author":"RB Koumangoye","year":"2011","unstructured":"Koumangoye RB, Sakwe AM, Goodwin JS, Patel T, Ochieng J: Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading. PLoS One. 2011, 6: e24234-10.1371\/journal.pone.0024234.","journal-title":"PLoS One"},{"key":"1091_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1586\/epr.09.17","volume":"6","author":"RJ Simpson","year":"2009","unstructured":"Simpson RJ, Lim JW, Moritz RL, Mathivanan S: Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics. 2009, 6: 267-283. 10.1586\/epr.09.17.","journal-title":"Expert Rev Proteomics"},{"key":"1091_CR10","first-page":"1107","volume":"28","author":"B Toth","year":"2008","unstructured":"Toth B, Nieuwland R, Liebhardt S, Ditsch N, Steinig K, Stieber P, Rank A, Gohring P, Thaler CJ, Friese K, Bauerfeind I: Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers. Anticancer Res. 2008, 28: 1107-1112.","journal-title":"Anticancer Res"},{"key":"1091_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","volume":"110","author":"DD Taylor","year":"2008","unstructured":"Taylor DD, Gercel-Taylor C: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008, 110: 13-21. 10.1016\/j.ygyno.2008.04.033.","journal-title":"Gynecol Oncol"},{"key":"1091_CR12","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ncb1800","volume":"10","author":"J Skog","year":"2008","unstructured":"Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT, Carter BS, Krichevsky AM, Breakefield XO: Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008, 10: 1470-1476. 10.1038\/ncb1800.","journal-title":"Nat Cell Biol"},{"key":"1091_CR13","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/sj.bjc.6605058","volume":"100","author":"J Nilsson","year":"2009","unstructured":"Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakefield XO, Widmark A: Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer. 2009, 100: 1603-1607. 10.1038\/sj.bjc.6605058.","journal-title":"Br J Cancer"},{"key":"1091_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1479-5876-7-4","volume":"7","author":"PJ Mitchell","year":"2009","unstructured":"Mitchell PJ, Welton J, Staffurth J, Court J, Mason MD, Tabi Z, Clayton A: Can urinary exosomes act as treatment response markers in prostate cancer?. J Transl Med. 2009, 7: 4-10.1186\/1479-5876-7-4.","journal-title":"J Transl Med"},{"key":"1091_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/ijc.2910410425","volume":"41","author":"DD Taylor","year":"1988","unstructured":"Taylor DD, Taylor CG, Jiang CG, Black PH: Characterization of plasma membrane shedding from murine melanoma cells. Int J Cancer. 1988, 41: 629-635. 10.1002\/ijc.2910410425.","journal-title":"Int J Cancer"},{"key":"1091_CR16","doi-asserted-by":"publisher","first-page":"e5219","DOI":"10.1371\/journal.pone.0005219","volume":"4","author":"M Logozzi","year":"2009","unstructured":"Logozzi M, De Milito A, Lugini L, Borghi M, Calabro L, Spada M, Perdicchio M, Marino ML, Federici C, Iessi E: High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One. 2009, 4: e5219-10.1371\/journal.pone.0005219.","journal-title":"PLoS One"},{"key":"1091_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1006\/gyno.2001.6551","volume":"84","author":"DD Taylor","year":"2002","unstructured":"Taylor DD, Lyons KS, Gercel-Taylor C: Shed membrane fragment-associated markers for endometrial and ovarian cancers. Gynecol Oncol. 2002, 84: 443-448. 10.1006\/gyno.2001.6551.","journal-title":"Gynecol Oncol"},{"key":"1091_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3816\/CLC.2009.n.006","volume":"10","author":"G Rabinowits","year":"2009","unstructured":"Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH: Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer. 2009, 10: 42-46. 10.3816\/CLC.2009.n.006.","journal-title":"Clin Lung Cancer"},{"key":"1091_CR19","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1084\/jem.183.3.1161","volume":"183","author":"G Raposo","year":"1996","unstructured":"Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ: B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996, 183: 1161-1172. 10.1084\/jem.183.3.1161.","journal-title":"J Exp Med"},{"key":"1091_CR20","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nm0598-594","volume":"4","author":"L Zitvogel","year":"1998","unstructured":"Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S: Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med. 1998, 4: 594-600. 10.1038\/nm0598-594.","journal-title":"Nat Med"},{"key":"1091_CR21","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/0092-8674(83)90040-5","volume":"33","author":"BT Pan","year":"1983","unstructured":"Pan BT, Johnstone RM: Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell. 1983, 33: 967-978. 10.1016\/0092-8674(83)90040-5.","journal-title":"Cell"},{"key":"1091_CR22","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.4049\/jimmunol.1100231","volume":"187","author":"H Sheng","year":"2011","unstructured":"Sheng H, Hassanali S, Nugent C, Wen L, Hamilton-Williams E, Dias P, Dai YD: Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice. J Immunol. 2011, 187: 1591-1600. 10.4049\/jimmunol.1100231.","journal-title":"J Immunol"},{"key":"1091_CR23","doi-asserted-by":"publisher","first-page":"e2461","DOI":"10.1371\/journal.pone.0002461","volume":"3","author":"PK Giri","year":"2008","unstructured":"Giri PK, Schorey JS: Exosomes derived from M. Bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo. PLoS One. 2008, 3: e2461-10.1371\/journal.pone.0002461.","journal-title":"PLoS One"},{"key":"1091_CR24","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.vaccine.2009.01.022","volume":"27","author":"C Beauvillain","year":"2009","unstructured":"Beauvillain C, Juste MO, Dion S, Pierre J, Dimier-Poisson I: Exosomes are an effective vaccine against congenital toxoplasmosis in mice. Vaccine. 2009, 27: 1750-1757. 10.1016\/j.vaccine.2009.01.022.","journal-title":"Vaccine"},{"key":"1091_CR25","doi-asserted-by":"publisher","first-page":"25779","DOI":"10.1074\/jbc.M702277200","volume":"282","author":"S Bhatnagar","year":"2007","unstructured":"Bhatnagar S, Schorey JS: Exosomes released from infected macrophages contain Mycobacterium avium glycopeptidolipids and are proinflammatory. J Biol Chem. 2007, 282: 25779-25789. 10.1074\/jbc.M702277200.","journal-title":"J Biol Chem"},{"key":"1091_CR26","doi-asserted-by":"publisher","first-page":"e4942","DOI":"10.1371\/journal.pone.0004942","volume":"4","author":"S Viaud","year":"2009","unstructured":"Viaud S, Terme M, Flament C, Taieb J, Andre F, Novault S, Escudier B, Robert C, Caillat-Zucman S, Tursz T: Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. PLoS One. 2009, 4: e4942-10.1371\/journal.pone.0004942.","journal-title":"PLoS One"},{"key":"1091_CR27","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1158\/0008-5472.CAN-09-3276","volume":"70","author":"S Viaud","year":"2010","unstructured":"Viaud S, Thery C, Ploix S, Tursz T, Lapierre V, Lantz O, Zitvogel L, Chaput N: Dendritic cell-derived exosomes for cancer immunotherapy: what's next?. Cancer Res. 2010, 70: 1281-1285. 10.1158\/0008-5472.CAN-09-3276.","journal-title":"Cancer Res"},{"key":"1091_CR28","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.4049\/jimmunol.176.5.2722","volume":"176","author":"J Taieb","year":"2006","unstructured":"Taieb J, Chaput N, Schartz N, Roux S, Novault S, Menard C, Ghiringhelli F, Terme M, Carpentier AF, Darrasse-Jeze G: Chemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccines. J Immunol. 2006, 176: 2722-2729.","journal-title":"J Immunol"},{"issue":"Suppl 4","key":"1091_CR29","doi-asserted-by":"crossref","first-page":"A28","DOI":"10.1016\/S0264-410X(02)00384-5","volume":"20","author":"F Andre","year":"2002","unstructured":"Andre F, Schartz NE, Chaput N, Flament C, Raposo G, Amigorena S, Angevin E, Zitvogel L: Tumor-derived exosomes: a new source of tumor rejection antigens. Vaccine. 2002, 20 (Suppl 4): A28-31.","journal-title":"Vaccine"},{"key":"1091_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0966-3274(03)00048-0","volume":"11","author":"TE Ichim","year":"2003","unstructured":"Ichim TE, Zhong R, Min WP: Prevention of allograft rejection by in vitro generated tolerogenic dendritic cells. Transpl Immunol. 2003, 11: 295-306. 10.1016\/S0966-3274(03)00048-0.","journal-title":"Transpl Immunol"},{"key":"1091_CR31","doi-asserted-by":"publisher","first-page":"R141","DOI":"10.1186\/ar2031","volume":"8","author":"I Popov","year":"2006","unstructured":"Popov I, Li M, Zheng X, San H, Zhang X, Ichim TE, Suzuki M, Feng B, Vladau C, Zhong R: Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine. Arthritis Res Ther. 2006, 8: R141-10.1186\/ar2031.","journal-title":"Arthritis Res Ther"},{"key":"1091_CR32","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.4049\/jimmunol.179.8.5024","volume":"179","author":"L Luketic","year":"2007","unstructured":"Luketic L, Delanghe J, Sobol PT, Yang P, Frotten E, Mossman KL, Gauldie J, Bramson J, Wan Y: Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL. J Immunol. 2007, 179: 5024-5032.","journal-title":"J Immunol"},{"key":"1091_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bcmd.2005.05.003","volume":"35","author":"E Segura","year":"2005","unstructured":"Segura E, Amigorena S, Thery C: Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells Mol Dis. 2005, 35: 89-93. 10.1016\/j.bcmd.2005.05.003.","journal-title":"Blood Cells Mol Dis"},{"key":"1091_CR34","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1002\/eji.200939407","volume":"39","author":"MA Ruffner","year":"2009","unstructured":"Ruffner MA, Kim SH, Bianco NR, Francisco LM, Sharpe AH, Robbins PD: B7-1\/2, but not PD-L1\/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function. Eur J Immunol. 2009, 39: 3084-3090. 10.1002\/eji.200939407.","journal-title":"Eur J Immunol"},{"key":"1091_CR35","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.jss.2010.05.021","volume":"171","author":"X Yang","year":"2011","unstructured":"Yang X, Meng S, Jiang H, Zhu C, Wu W: Exosomes derived from immature bone marrow dendritic cells induce tolerogenicity of intestinal transplantation in rats. J Surg Res. 2011, 171: 826-832. 10.1016\/j.jss.2010.05.021.","journal-title":"J Surg Res"},{"key":"1091_CR36","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/j.1600-6143.2006.01344.x","volume":"6","author":"H Peche","year":"2006","unstructured":"Peche H, Renaudin K, Beriou G, Merieau E, Amigorena S, Cuturi MC: Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model. Am J Transplant. 2006, 6: 1541-1550. 10.1111\/j.1600-6143.2006.01344.x.","journal-title":"Am J Transplant"},{"key":"1091_CR37","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.4049\/jimmunol.179.4.2235","volume":"179","author":"SH Kim","year":"2007","unstructured":"Kim SH, Bianco NR, Shufesky WJ, Morelli AE, Robbins PD: MHC class II\u2009+\u2009exosomes in plasma suppress inflammation in an antigen-specific and Fas ligand\/Fas-dependent manner. J Immunol. 2007, 179: 2235-2241.","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"1091_CR38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0897.2011.01049.x","volume":"66","author":"J Ernerudh","year":"2011","unstructured":"Ernerudh J, Berg G, Mjosberg J: Regulatory T helper cells in pregnancy and their roles in systemic versus local immune tolerance. Am J Reprod Immunol. 2011, 66 (Suppl 1): 31-43.","journal-title":"Am J Reprod Immunol"},{"key":"1091_CR39","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11684-010-0101-y","volume":"4","author":"QD Lin","year":"2010","unstructured":"Lin QD, Qiu LH: Pathogenesis, diagnosis, and treatment of recurrent spontaneous abortion with immune type. Front Med China. 2010, 4: 275-279. 10.1007\/s11684-010-0101-y.","journal-title":"Front Med China"},{"key":"1091_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00404-004-0706-y","volume":"272","author":"MK Pandey","year":"2005","unstructured":"Pandey MK, Rani R, Agrawal S: An update in recurrent spontaneous abortion. Arch Gynecol Obstet. 2005, 272: 95-108. 10.1007\/s00404-004-0706-y.","journal-title":"Arch Gynecol Obstet"},{"key":"1091_CR41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/molehr\/gah129","volume":"11","author":"L Frangsmyr","year":"2005","unstructured":"Frangsmyr L, Baranov V, Nagaeva O, Stendahl U, Kjellberg L, Mincheva-Nilsson L: Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol Hum Reprod. 2005, 11: 35-41.","journal-title":"Mol Hum Reprod"},{"key":"1091_CR42","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.4049\/jimmunol.176.3.1534","volume":"176","author":"DD Taylor","year":"2006","unstructured":"Taylor DD, Akyol S, Gercel-Taylor C: Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol. 2006, 176: 1534-1542.","journal-title":"J Immunol"},{"key":"1091_CR43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1600-0897.2006.00435.x","volume":"56","author":"A Sabapatha","year":"2006","unstructured":"Sabapatha A, Gercel-Taylor C, Taylor DD: Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reprod Immunol. 2006, 56: 345-355. 10.1111\/j.1600-0897.2006.00435.x.","journal-title":"Am J Reprod Immunol"},{"key":"1091_CR44","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.4049\/jimmunol.176.6.3585","volume":"176","author":"L Mincheva-Nilsson","year":"2006","unstructured":"Mincheva-Nilsson L, Nagaeva O, Chen T, Stendahl U, Antsiferova J, Mogren I, Hernestal J, Baranov V: Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival. J Immunol. 2006, 176: 3585-3592.","journal-title":"J Immunol"},{"key":"1091_CR45","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4049\/jimmunol.0803477","volume":"183","author":"M Hedlund","year":"2009","unstructured":"Hedlund M, Stenqvist AC, Nagaeva O, Kjellberg L, Wulff M, Baranov V, Mincheva-Nilsson L: Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J Immunol. 2009, 183: 340-351. 10.4049\/jimmunol.0803477.","journal-title":"J Immunol"},{"key":"1091_CR46","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/ard.2007.075283","volume":"67","author":"F Forger","year":"2008","unstructured":"Forger F, Marcoli N, Gadola S, Moller B, Villiger PM, Ostensen M: Pregnancy induces numerical and functional changes of CD4\u2009+\u2009CD25 high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis. 2008, 67: 984-990.","journal-title":"Ann Rheum Dis"},{"key":"1091_CR47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2249.2007.03555.x","volume":"151","author":"L Airas","year":"2008","unstructured":"Airas L, Saraste M, Rinta S, Elovaara I, Huang YH, Wiendl H: Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells. Clin Exp Immunol. 2008, 151: 235-243.","journal-title":"Clin Exp Immunol"},{"key":"1091_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jneuroim.2010.09.010","volume":"230","author":"NN Gatson","year":"2011","unstructured":"Gatson NN, Williams JL, Powell ND, McClain MA, Hennon TR, Robbins PD, Whitacre CC: Induction of pregnancy during established EAE halts progression of CNS autoimmune injury via pregnancy-specific serum factors. J Neuroimmunol. 2011, 230: 105-113. 10.1016\/j.jneuroim.2010.09.010.","journal-title":"J Neuroimmunol"},{"key":"1091_CR49","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1600-065X.2011.01017.x","volume":"241","author":"HL Weiner","year":"2011","unstructured":"Weiner HL, da Cunha AP, Quintana F, Wu H: Oral tolerance. Immunol Rev. 2011, 241: 241-259. 10.1111\/j.1600-065X.2011.01017.x.","journal-title":"Immunol Rev"},{"key":"1091_CR50","doi-asserted-by":"publisher","first-page":"R180","DOI":"10.1186\/ar2870","volume":"11","author":"W Wei","year":"2009","unstructured":"Wei W, Zhang LL, Xu JH, Xiao F, Bao CD, Ni LQ, Li XF, Wu YQ, Sun LY, Zhang RH: A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis. Arthritis Res Ther. 2009, 11: R180-10.1186\/ar2870.","journal-title":"Arthritis Res Ther"},{"key":"1091_CR51","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.4049\/jimmunol.162.10.6247","volume":"162","author":"JM Benson","year":"1999","unstructured":"Benson JM, Stuckman SS, Cox KL, Wardrop RM, Gienapp IE, Cross AH, Trotter JL, Whitacre CC: Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis. J Immunol. 1999, 162: 6247-6254.","journal-title":"J Immunol"},{"key":"1091_CR52","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1749-6632.1997.tb48623.x","volume":"835","author":"DA Hafler","year":"1997","unstructured":"Hafler DA, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Fukaura H: Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis. Ann N Y Acad Sci. 1997, 835: 120-131. 10.1111\/j.1749-6632.1997.tb48623.x.","journal-title":"Ann N Y Acad Sci"},{"key":"1091_CR53","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1002\/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I","volume":"31","author":"M Karlsson","year":"2001","unstructured":"Karlsson M, Lundin S, Dahlgren U, Kahu H, Pettersson I, Telemo E: \"Tolerosomes\" are produced by intestinal epithelial cells. Eur J Immunol. 2001, 31: 2892-2900. 10.1002\/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I.","journal-title":"Eur J Immunol"},{"key":"1091_CR54","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2567.2005.02245.x","volume":"116","author":"S Ostman","year":"2005","unstructured":"Ostman S, Taube M, Telemo E: Tolerosome-induced oral tolerance is MHC dependent. Immunology. 2005, 116: 464-476.","journal-title":"Immunology"},{"key":"1091_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1365-2567.2008.02812.x","volume":"125","author":"N Almqvist","year":"2008","unstructured":"Almqvist N, Lonnqvist A, Hultkrantz S, Rask C, Telemo E: Serum-derived exosomes from antigen-fed mice prevent allergic sensitization in a model of allergic asthma. Immunology. 2008, 125: 21-27. 10.1111\/j.1365-2567.2008.02812.x.","journal-title":"Immunology"},{"key":"1091_CR56","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007, 9: 654-659. 10.1038\/ncb1596.","journal-title":"Nat Cell Biol"},{"key":"1091_CR57","doi-asserted-by":"publisher","first-page":"676","DOI":"10.4049\/jimmunol.1003884","volume":"187","author":"A Clayton","year":"2011","unstructured":"Clayton A, Al-Taei S, Webber J, Mason MD, Tabi Z: Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J Immunol. 2011, 187: 676-683. 10.4049\/jimmunol.1003884.","journal-title":"J Immunol"},{"key":"1091_CR58","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1158\/1078-0432.1010.11.3","volume":"11","author":"JW Kim","year":"2005","unstructured":"Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, Whiteside TL: Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res. 2005, 11: 1010-1020.","journal-title":"Clin Cancer Res"},{"key":"1091_CR59","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ymthe.2005.09.015","volume":"13","author":"SH Kim","year":"2006","unstructured":"Kim SH, Bianco N, Menon R, Lechman ER, Shufesky WJ, Morelli AE, Robbins PD: Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive. Mol Ther. 2006, 13: 289-300. 10.1016\/j.ymthe.2005.09.015.","journal-title":"Mol Ther"},{"key":"1091_CR60","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bcmd.2005.07.001","volume":"35","author":"AJ Abusamra","year":"2005","unstructured":"Abusamra AJ, Zhong Z, Zheng X, Li M, Ichim TE, Chin JL, Min WP: Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol Dis. 2005, 35: 169-173. 10.1016\/j.bcmd.2005.07.001.","journal-title":"Blood Cells Mol Dis"},{"key":"1091_CR61","first-page":"749","volume":"25","author":"P Peng","year":"2011","unstructured":"Peng P, Yan Y, Keng S: Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity. Oncol Rep. 2011, 25: 749-762.","journal-title":"Oncol Rep"},{"key":"1091_CR62","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.4049\/jimmunol.167.12.6736","volume":"167","author":"I Monleon","year":"2001","unstructured":"Monleon I, Martinez-Lorenzo MJ, Monteagudo L, Lasierra P, Taules M, Iturralde M, Pineiro A, Larrad L, Alava MA, Naval J, Anel A: Differential secretion of Fas ligand- or APO2 ligand\/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells. J Immunol. 2001, 167: 6736-6744.","journal-title":"J Immunol"},{"key":"1091_CR63","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/hed.20968","volume":"31","author":"C Bergmann","year":"2009","unstructured":"Bergmann C, Strauss L, Wieckowski E, Czystowska M, Albers A, Wang Y, Zeidler R, Lang S, Whiteside TL: Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression. Head Neck. 2009, 31: 371-380. 10.1002\/hed.20968.","journal-title":"Head Neck"},{"key":"1091_CR64","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bjc.6602316","volume":"92","author":"DD Taylor","year":"2005","unstructured":"Taylor DD, Gercel-Taylor C: Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br J Cancer. 2005, 92: 305-311.","journal-title":"Br J Cancer"},{"key":"1091_CR65","first-page":"5113","volume":"9","author":"DD Taylor","year":"2003","unstructured":"Taylor DD, Gercel-Taylor C, Lyons KS, Stanson J, Whiteside TL: T-cell apoptosis and suppression of T-cell receptor\/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors. Clin Cancer Res. 2003, 9: 5113-5119.","journal-title":"Clin Cancer Res"},{"key":"1091_CR66","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1089\/cbr.2009.0660","volume":"24","author":"VT Cheriyan","year":"2009","unstructured":"Cheriyan VT, Krishna SM, Kumar A, Jayaprakash PG, Balaram P: Signaling defects and functional impairment in T-cells from cervical cancer patients. Cancer Biother Radiopharm. 2009, 24: 667-673. 10.1089\/cbr.2009.0660.","journal-title":"Cancer Biother Radiopharm"},{"key":"1091_CR67","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.canep.2009.10.011","volume":"33","author":"P Zielinski","year":"2009","unstructured":"Zielinski P, Dyszkiewicz W, Piwkowski CT, Dworacki G, Gasiorowski L: Can the condition of the cell microenvironment of mediastinal lymph nodes help predict the risk of metastases in non-small cell lung cancer?. Cancer Epidemiol. 2009, 33: 387-390. 10.1016\/j.canep.2009.10.011.","journal-title":"Cancer Epidemiol"},{"key":"1091_CR68","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/ijc.24137","volume":"124","author":"DP Kulkarni","year":"2009","unstructured":"Kulkarni DP, Wadia PP, Pradhan TN, Pathak AK, Chiplunkar SV: Mechanisms involved in the down-regulation of TCR zeta chain in tumor versus peripheral blood of oral cancer patients. Int J Cancer. 2009, 124: 1605-1613. 10.1002\/ijc.24137.","journal-title":"Int J Cancer"},{"key":"1091_CR69","first-page":"779","volume":"28","author":"IV Gruber","year":"2008","unstructured":"Gruber IV, El Yousfi S, Durr-Storzer S, Wallwiener D, Solomayer EF, Fehm T: Down-regulation of CD28, TCR-zeta (zeta) and up-regulation of FAS in peripheral cytotoxic T-cells of primary breast cancer patients. Anticancer Res. 2008, 28: 779-784.","journal-title":"Anticancer Res"},{"key":"1091_CR70","first-page":"947s","volume":"7","author":"G Dworacki","year":"2001","unstructured":"Dworacki G, Meidenbauer N, Kuss I, Hoffmann TK, Gooding W, Lotze M, Whiteside TL: Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma. Clin Cancer Res. 2001, 7: 947s-957s.","journal-title":"Clin Cancer Res"},{"key":"1091_CR71","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s002620050585","volume":"48","author":"TL Whiteside","year":"1999","unstructured":"Whiteside TL: Signaling defects in T lymphocytes of patients with malignancy. Cancer Immunol Immunother. 1999, 48: 346-352. 10.1007\/s002620050585.","journal-title":"Cancer Immunol Immunother"},{"key":"1091_CR72","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.166.1.678","volume":"166","author":"B Almand","year":"2001","unstructured":"Almand B, Clark JI, Nikitina E, van Beynen J, English NR, Knight SC, Carbone DP, Gabrilovich DI: Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol. 2001, 166: 678-689.","journal-title":"J Immunol"},{"key":"1091_CR73","doi-asserted-by":"publisher","first-page":"9299","DOI":"10.1158\/0008-5472.CAN-06-1690","volume":"66","author":"N Mirza","year":"2006","unstructured":"Mirza N, Fishman M, Fricke I, Dunn M, Neuger AM, Frost TJ, Lush RM, Antonia S, Gabrilovich DI: All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Res. 2006, 66: 9299-9307. 10.1158\/0008-5472.CAN-06-1690.","journal-title":"Cancer Res"},{"key":"1091_CR74","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00262-008-0523-4","volume":"58","author":"CM Diaz-Montero","year":"2009","unstructured":"Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ: Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother. 2009, 58: 49-59. 10.1007\/s00262-008-0523-4.","journal-title":"Cancer Immunol Immunother"},{"key":"1091_CR75","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1002\/ijc.24249","volume":"124","author":"X Xiang","year":"2009","unstructured":"Xiang X, Poliakov A, Liu C, Liu Y, Deng ZB, Wang J, Cheng Z, Shah SV, Wang GJ, Zhang L: Induction of myeloid-derived suppressor cells by tumor exosomes. Int J Cancer. 2009, 124: 2621-2633. 10.1002\/ijc.24249.","journal-title":"Int J Cancer"},{"key":"1091_CR76","first-page":"457","volume":"120","author":"F Chalmin","year":"2010","unstructured":"Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin JP, Boireau W, Rouleau A, Simon B, Lanneau D: Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest. 2010, 120: 457-471.","journal-title":"J Clin Invest"},{"key":"1091_CR77","doi-asserted-by":"crossref","first-page":"430394","DOI":"10.1155\/2011\/430394","volume":"2011","author":"N Janikashvili","year":"2011","unstructured":"Janikashvili N, Bonnotte B, Katsanis E, Larmonier N: The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance. Clin Dev Immunol. 2011, 2011: 430394-","journal-title":"Clin Dev Immunol"},{"key":"1091_CR78","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.4049\/jimmunol.178.11.6867","volume":"178","author":"S Yu","year":"2007","unstructured":"Yu S, Liu C, Su K, Wang J, Liu Y, Zhang L, Li C, Cong Y, Kimberly R, Grizzle WE: Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J Immunol. 2007, 178: 6867-6875.","journal-title":"J Immunol"},{"key":"1091_CR79","doi-asserted-by":"publisher","first-page":"9290","DOI":"10.1158\/0008-5472.CAN-06-1819","volume":"66","author":"R Valenti","year":"2006","unstructured":"Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, Corbelli A, Fais S, Parmiani G, Rivoltini L: Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res. 2006, 66: 9290-9298. 10.1158\/0008-5472.CAN-06-1819.","journal-title":"Cancer Res"},{"key":"1091_CR80","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nri2808","volume":"10","author":"RA Flavell","year":"2010","unstructured":"Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Limon P: The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol. 2010, 10: 554-567. 10.1038\/nri2808.","journal-title":"Nat Rev Immunol"},{"key":"1091_CR81","first-page":"3747","volume":"30","author":"J Wada","year":"2010","unstructured":"Wada J, Onishi H, Suzuki H, Yamasaki A, Nagai S, Morisaki T, Katano M: Surface-bound TGF-beta1 on effusion-derived exosomes participates in maintenance of number and suppressive function of regulatory T-cells in malignant effusions. Anticancer Res. 2010, 30: 3747-3757.","journal-title":"Anticancer Res"},{"key":"1091_CR82","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.4049\/jimmunol.0900970","volume":"183","author":"EU Wieckowski","year":"2009","unstructured":"Wieckowski EU, Visus C, Szajnik M, Szczepanski MJ, Storkus WJ, Whiteside TL: Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J Immunol. 2009, 183: 3720-3730. 10.4049\/jimmunol.0900970.","journal-title":"J Immunol"},{"key":"1091_CR83","doi-asserted-by":"publisher","first-page":"e11469","DOI":"10.1371\/journal.pone.0011469","volume":"5","author":"M Szajnik","year":"2010","unstructured":"Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M, Whiteside TL: Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One. 2010, 5: e11469-10.1371\/journal.pone.0011469.","journal-title":"PLoS One"},{"key":"1091_CR84","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.immuni.2008.02.016","volume":"28","author":"N Guerra","year":"2008","unstructured":"Guerra N, Tan YX, Joncker NT, Choy A, Gallardo F, Xiong N, Knoblaugh S, Cado D, Greenberg NM, Raulet DH: NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity. 2008, 28: 571-580. 10.1016\/j.immuni.2008.02.016.","journal-title":"Immunity"},{"key":"1091_CR85","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nri1199","volume":"3","author":"DH Raulet","year":"2003","unstructured":"Raulet DH: Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol. 2003, 3: 781-790. 10.1038\/nri1199.","journal-title":"Nat Rev Immunol"},{"key":"1091_CR86","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/nature03884","volume":"436","author":"S Gasser","year":"2005","unstructured":"Gasser S, Orsulic S, Brown EJ, Raulet DH: The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 2005, 436: 1186-1190. 10.1038\/nature03884.","journal-title":"Nature"},{"key":"1091_CR87","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature05953","volume":"448","author":"D Dominguez-Sola","year":"2007","unstructured":"Dominguez-Sola D, Ying CY, Grandori C, Ruggiero L, Chen B, Li M, Galloway DA, Gu W, Gautier J, Dalla-Favera R: Non-transcriptional control of DNA replication by c-Myc. Nature. 2007, 448: 445-451. 10.1038\/nature05953.","journal-title":"Nature"},{"key":"1091_CR88","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/nature01112","volume":"419","author":"V Groh","year":"2002","unstructured":"Groh V, Wu J, Yee C, Spies T: Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature. 2002, 419: 734-738. 10.1038\/nature01112.","journal-title":"Nature"},{"key":"1091_CR89","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bcmd.2005.03.003","volume":"34","author":"A Clayton","year":"2005","unstructured":"Clayton A, Tabi Z: Exosomes and the MICA-NKG2D system in cancer. Blood Cells Mol Dis. 2005, 34: 206-213. 10.1016\/j.bcmd.2005.03.003.","journal-title":"Blood Cells Mol Dis"},{"key":"1091_CR90","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.4049\/jimmunol.180.11.7249","volume":"180","author":"A Clayton","year":"2008","unstructured":"Clayton A, Mitchell JP, Court J, Linnane S, Mason MD, Tabi Z: Human tumor-derived exosomes down-modulate NKG2D expression. J Immunol. 2008, 180: 7249-7258.","journal-title":"J Immunol"},{"key":"1091_CR91","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1158\/0008-5472.CAN-09-1688","volume":"70","author":"O Ashiru","year":"2010","unstructured":"Ashiru O, Boutet P, Fernandez-Messina L, Aguera-Gonzalez S, Skepper JN, Vales-Gomez M, Reyburn HT: Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. Cancer Res. 2010, 70: 481-489. 10.1158\/0008-5472.CAN-09-1688.","journal-title":"Cancer Res"},{"key":"1091_CR92","doi-asserted-by":"publisher","first-page":"e16899","DOI":"10.1371\/journal.pone.0016899","volume":"6","author":"M Hedlund","year":"2011","unstructured":"Hedlund M, Nagaeva O, Kargl D, Baranov V, Mincheva-Nilsson L: Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia\/lymphoma T and B cells. PLoS One. 2011, 6: e16899-10.1371\/journal.pone.0016899.","journal-title":"PLoS One"},{"key":"1091_CR93","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4049\/jimmunol.172.12.7335","volume":"172","author":"JC Lee","year":"2004","unstructured":"Lee JC, Lee KM, Kim DW, Heo DS: Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. J Immunol. 2004, 172: 7335-7340.","journal-title":"J Immunol"},{"key":"1091_CR94","doi-asserted-by":"publisher","first-page":"8543","DOI":"10.1074\/jbc.M109.045906","volume":"285","author":"L Fernandez-Messina","year":"2010","unstructured":"Fernandez-Messina L, Ashiru O, Boutet P, Aguera-Gonzalez S, Skepper JN, Reyburn HT, Vales-Gomez M: Differential mechanisms of shedding of the glycosylphosphatidylinositol (GPI)-anchored NKG2D ligands. J Biol Chem. 2010, 285: 8543-8551. 10.1074\/jbc.M109.045906.","journal-title":"J Biol Chem"},{"key":"1091_CR95","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/313144a0","volume":"313","author":"TA Libermann","year":"1985","unstructured":"Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J: Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature. 1985, 313: 144-147. 10.1038\/313144a0.","journal-title":"Nature"},{"key":"1091_CR96","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/1389450053765879","volume":"6","author":"N Normanno","year":"2005","unstructured":"Normanno N, Bianco C, Strizzi L, Mancino M, Maiello MR, De Luca A, Caponigro F, Salomon DS: The ErbB receptors and their ligands in cancer: an overview. Curr Drug Targets. 2005, 6: 243-257. 10.2174\/1389450053765879.","journal-title":"Curr Drug Targets"},{"key":"1091_CR97","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1038\/onc.2010.112","volume":"29","author":"SE Wang","year":"2010","unstructured":"Wang SE, Yu Y, Criswell TL, Debusk LM, Lin PC, Zent R, Johnson DH, Ren X, Arteaga CL: Oncogenic mutations regulate tumor microenvironment through induction of growth factors and angiogenic mediators. Oncogene. 2010, 29: 3335-3348. 10.1038\/onc.2010.112.","journal-title":"Oncogene"},{"key":"1091_CR98","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1158\/1078-0432.CCR-10-2475","volume":"17","author":"K Yasumoto","year":"2011","unstructured":"Yasumoto K, Yamada T, Kawashima A, Wang W, Li Q, Donev IS, Tacheuchi S, Mouri H, Yamashita K, Ohtsubo K, Yano S: The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer. Clin Cancer Res. 2011, 17: 3619-3630. 10.1158\/1078-0432.CCR-10-2475.","journal-title":"Clin Cancer Res"},{"key":"1091_CR99","first-page":"3703","volume":"25","author":"K Koga","year":"2005","unstructured":"Koga K, Matsumoto K, Akiyoshi T, Kubo M, Yamanaka N, Tasaki A, Nakashima H, Nakamura M, Kuroki S, Tanaka M, Katano M: Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res. 2005, 25: 3703-3707.","journal-title":"Anticancer Res"},{"key":"1091_CR100","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00262-011-0979-5","volume":"60","author":"C Battke","year":"2011","unstructured":"Battke C, Ruiss R, Welsch U, Wimberger P, Lang S, Jochum S, Zeidler R: Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC. Cancer Immunol Immunother. 2011, 60: 639-648. 10.1007\/s00262-011-0979-5.","journal-title":"Cancer Immunol Immunother"},{"key":"1091_CR101","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/jcp.22773","volume":"227","author":"V Ciravolo","year":"2012","unstructured":"Ciravolo V, Huber V, Ghedini GC, Venturelli E, Bianchi F, Campiglio M, Morelli D, Villa A, Mina PD, Menard S: Potential role of HER2-overexpressing exosomes in countering Trastuzumab-based therapy. J Cell Physiol. 2012, 227: 658-667. 10.1002\/jcp.22773.","journal-title":"J Cell Physiol"},{"key":"1091_CR102","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.lfs.2011.06.020","volume":"89","author":"KA Adamczyk","year":"2011","unstructured":"Adamczyk KA, Klein-Scory S, Tehrani MM, Warnken U, Schmiegel W, Schnolzer M, Schwarte-Waldhoff I: Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells. Life Sci. 2011, 89: 304-312. 10.1016\/j.lfs.2011.06.020.","journal-title":"Life Sci"},{"key":"1091_CR103","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1096\/fj.08-122184","volume":"23","author":"MW Graner","year":"2009","unstructured":"Graner MW, Alzate O, Dechkovskaia AM, Keene JD, Sampson JH, Mitchell DA, Bigner DD: Proteomic and immunologic analyses of brain tumor exosomes. FASEB J. 2009, 23: 1541-1557. 10.1096\/fj.08-122184.","journal-title":"FASEB J"},{"key":"1091_CR104","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/ncb1725","volume":"10","author":"K Al-Nedawi","year":"2008","unstructured":"Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, Rak J: Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol. 2008, 10: 619-624. 10.1038\/ncb1725.","journal-title":"Nat Cell Biol"},{"key":"1091_CR105","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00262-009-0808-2","volume":"59","author":"J Baran","year":"2010","unstructured":"Baran J, Baj-Krzyworzeka M, Weglarczyk K, Szatanek R, Zembala M, Barbasz J, Czupryna A, Szczepanik A: Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother. 2010, 59: 841-850. 10.1007\/s00262-009-0808-2.","journal-title":"Cancer Immunol Immunother"},{"key":"1091_CR106","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1517\/14712591003689972","volume":"10","author":"E Tagliabue","year":"2010","unstructured":"Tagliabue E, Balsari A, Campiglio M, Pupa SM: HER2 as a target for breast cancer therapy. Expert Opin Biol Ther. 2010, 10: 711-724. 10.1517\/14712591003689972.","journal-title":"Expert Opin Biol Ther"},{"key":"1091_CR107","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.cub.2011.03.043","volume":"21","author":"JN Higginbotham","year":"2011","unstructured":"Higginbotham JN, Demory Beckler M, Gephart JD, Franklin JL, Bogatcheva G, Kremers GJ, Piston DW, Ayers GD, McConnell RE, Tyska MJ, Coffey RJ: Amphiregulin exosomes increase cancer cell invasion. Curr Biol. 2011, 21: 779-786. 10.1016\/j.cub.2011.03.043.","journal-title":"Curr Biol"},{"key":"1091_CR108","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1073\/pnas.0804543106","volume":"106","author":"K Al-Nedawi","year":"2009","unstructured":"Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J: Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A. 2009, 106: 3794-3799. 10.1073\/pnas.0804543106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1091_CR109","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ncponc0509","volume":"3","author":"R Nahta","year":"2006","unstructured":"Nahta R, Yu D, Hung MC, Hortobagyi GN, Esteva FJ: Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nat Clin Pract Oncol. 2006, 3: 269-280. 10.1038\/ncponc0509.","journal-title":"Nat Clin Pract Oncol"},{"key":"1091_CR110","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/bcr1612","volume":"8","author":"R Nahta","year":"2006","unstructured":"Nahta R, Esteva FJ: HER2 therapy: molecular mechanisms of trastuzumab resistance. Breast Cancer Res. 2006, 8: 215-10.1186\/bcr1612.","journal-title":"Breast Cancer Res"},{"key":"1091_CR111","first-page":"87","volume":"5","author":"H Abdel-Razeq","year":"2011","unstructured":"Abdel-Razeq H, Marei L: Current neoadjuvant treatment options for HER2-positive breast cancer. Biologics. 2011, 5: 87-94.","journal-title":"Biologics"},{"key":"1091_CR112","first-page":"20","volume":"26","author":"G Von Minckwitz","year":"2012","unstructured":"Von Minckwitz G, Loibl S, Untch M: What is the current standard of care for anti-HER2 neoadjuvant therapy in breast cancer?. Oncology (Williston Park). 2012, 26: 20-26.","journal-title":"Oncology (Williston Park)"},{"key":"1091_CR113","volume-title":"J Clin Oncol","author":"N Niikura","year":"2011","unstructured":"Niikura N, Liu J, Hayashi N, Mittendorf EA, Gong Y, Palla SL, Tokuda Y, Gonzalez-Angulo AM, Hortobagyi GN, Ueno NT:NT: Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors.J Clin Oncol. 2011,"},{"key":"1091_CR114","doi-asserted-by":"publisher","first-page":"15336","DOI":"10.1073\/pnas.1102855108","volume":"108","author":"T Aung","year":"2011","unstructured":"Aung T, Chapuy B, Vogel D, Wenzel D, Oppermann M, Lahmann M, Weinhage T, Menck K, Hupfeld T, Koch R: Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc Natl Acad Sci U S A. 2011, 108: 15336-15341. 10.1073\/pnas.1102855108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1091_CR115","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1158\/1535-7163.MCT-05-0102","volume":"4","author":"R Safaei","year":"2005","unstructured":"Safaei R, Larson BJ, Cheng TC, Gibson MA, Otani S, Naerdemann W, Howell SB: Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther. 2005, 4: 1595-1604. 10.1158\/1535-7163.MCT-05-0102.","journal-title":"Mol Cancer Ther"},{"key":"1091_CR116","doi-asserted-by":"publisher","first-page":"9903","DOI":"10.1073\/pnas.0600213103","volume":"103","author":"KG Chen","year":"2006","unstructured":"Chen KG, Valencia JC, Lai B, Zhang G, Paterson JK, Rouzaud F, Berens W, Wincovitch SM, Garfield SH, Leapman RD: Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas. Proc Natl Acad Sci U S A. 2006, 103: 9903-9907. 10.1073\/pnas.0600213103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1091_CR117","first-page":"4331","volume":"63","author":"K Shedden","year":"2003","unstructured":"Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR: Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res. 2003, 63: 4331-4337.","journal-title":"Cancer Res"},{"key":"1091_CR118","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.cdd.4402237","volume":"15","author":"M Iero","year":"2008","unstructured":"Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S, Rivoltini L: Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ. 2008, 15: 80-88. 10.1038\/sj.cdd.4402237.","journal-title":"Cell Death Differ"},{"key":"1091_CR119","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.bbamcr.2007.04.015","volume":"1773","author":"HG Zhang","year":"2007","unstructured":"Zhang HG, Kim H, Liu C, Yu S, Wang J, Grizzle WE, Kimberly RP, Barnes S: Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochim Biophys Acta. 2007, 1773: 1116-1123. 10.1016\/j.bbamcr.2007.04.015.","journal-title":"Biochim Biophys Acta"},{"key":"1091_CR120","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/jnci\/djh305","volume":"96","author":"F Luciani","year":"2004","unstructured":"Luciani F, Spada M, De Milito A, Molinari A, Rivoltini L, Montinaro A, Marra M, Lugini L, Logozzi M, Lozupone F: Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst. 2004, 96: 1702-1713. 10.1093\/jnci\/djh305.","journal-title":"J Natl Cancer Inst"},{"key":"1091_CR121","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/ijc.25009","volume":"127","author":"A De Milito","year":"2010","unstructured":"De Milito A, Canese R, Marino ML, Borghi M, Iero M, Villa A, Venturi G, Lozupone F, Iessi E, Logozzi M: pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer. 2010, 127: 207-219. 10.1002\/ijc.25009.","journal-title":"Int J Cancer"},{"key":"1091_CR122","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1756-9966-29-44","volume":"29","author":"EP Spugnini","year":"2010","unstructured":"Spugnini EP, Citro G, Fais S: Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy. J Exp Clin Cancer Res. 2010, 29: 44-10.1186\/1756-9966-29-44.","journal-title":"J Exp Clin Cancer Res"},{"key":"1091_CR123","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1126\/science.1153124","volume":"319","author":"K Trajkovic","year":"2008","unstructured":"Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brugger B, Simons M: Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008, 319: 1244-1247. 10.1126\/science.1153124.","journal-title":"Science"},{"key":"1091_CR124","first-page":"511","volume":"8","author":"MR Lentz","year":"1989","unstructured":"Lentz MR: Continuous whole blood UltraPheresis procedure in patients with metastatic cancer. J Biol Response Mod. 1989, 8: 511-527.","journal-title":"J Biol Response Mod"},{"key":"1091_CR125","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1046\/j.1526-0968.1999.00147.x","volume":"3","author":"MR Lentz","year":"1999","unstructured":"Lentz MR: The role of therapeutic apheresis in the treatment of cancer: a review. Ther Apher. 1999, 3: 40-49. 10.1046\/j.1526-0968.1999.00147.x.","journal-title":"Ther Apher"},{"key":"1091_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jca.2920060102","volume":"6","author":"HW Snyder","year":"1991","unstructured":"Snyder HW, Henry DH, Messerschmidt GL, Mittelman A, Bertram J, Ambinder E, Kiprov D, Balint JP, MacKintosh FR, Hamburger M: Minimal toxicity during protein A immunoadsorption treatment of malignant disease: an outpatient therapy. J Clin Apher. 1991, 6: 1-10. 10.1002\/jca.2920060102.","journal-title":"J Clin Apher"},{"key":"1091_CR127","first-page":"31","volume":"26","author":"HW Snyder","year":"1989","unstructured":"Snyder HW, Balint JP, Jones FR: Modulation of immunity in patients with autoimmune disease and cancer treated by extracorporeal immunoadsorption with PROSORBA columns. Semin Hematol. 1989, 26: 31-41.","journal-title":"Semin Hematol"},{"key":"1091_CR128","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/1097-0142(19950415)75:8<2099::AID-CNCR2820750812>3.0.CO;2-I","volume":"75","author":"DW Fennelly","year":"1995","unstructured":"Fennelly DW, Norton L, Sznol M, Hakes TB: A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer. Cancer. 1995, 75: 2099-2102. 10.1002\/1097-0142(19950415)75:8<2099::AID-CNCR2820750812>3.0.CO;2-I.","journal-title":"Cancer"},{"key":"1091_CR129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000167011","volume":"27","author":"RH Tullis","year":"2009","unstructured":"Tullis RH, Duffin RP, Handley HH, Sodhi P, Menon J, Joyce JA, Kher V: Reduction of hepatitis C virus using lectin affinity plasmapheresis in dialysis patients. Blood Purif. 2009, 27: 64-69.","journal-title":"Blood Purif"},{"key":"1091_CR130","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1471-2407-11-108","volume":"11","author":"C Escrevente","year":"2011","unstructured":"Escrevente C, Keller S, Altevogt P, Costa J: Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer. 2011, 11: 108-10.1186\/1471-2407-11-108.","journal-title":"BMC Cancer"},{"key":"1091_CR131","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1021\/pr200434y","volume":"10","author":"BS Batista","year":"2011","unstructured":"Batista BS, Eng WS, Pilobello KT, Hendricks-Munoz KD, Mahal LK: Identification of a conserved glycan signature for microvesicles. J Proteome Res. 2011, 10: 4624-4633. 10.1021\/pr200434y.","journal-title":"J Proteome Res"},{"key":"1091_CR132","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nchembio0409-198","volume":"5","author":"J Hirabayashi","year":"2009","unstructured":"Hirabayashi J: Glycome 'fingerprints' provide definitive clues to HIV origins. Nat Chem Biol. 2009, 5: 198-199.","journal-title":"Nat Chem Biol"},{"key":"1091_CR133","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1046\/j.1526-0968.2002.00407.x","volume":"6","author":"RH Tullis","year":"2002","unstructured":"Tullis RH, Duffin RP, Zech M, Ambrus JL: Affinity hemodialysis for antiviral therapy. I. Removal of HIV-1 from cell culture supernatants, plasma, and blood. Ther Apher. 2002, 6: 213-220. 10.1046\/j.1526-0968.2002.00407.x.","journal-title":"Ther Apher"},{"key":"1091_CR134","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000067865","volume":"21","author":"RH Tullis","year":"2003","unstructured":"Tullis RH, Duffin RP, Zech M, Ambrus JL: Affinity hemodialysis for antiviral therapy. II. Removal of HIV-1 viral proteins from cell culture supernatants and whole blood. Blood Purif. 2003, 21: 58-63. 10.1159\/000067865.","journal-title":"Blood Purif"},{"key":"1091_CR135","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/(SICI)1097-0215(19971210)73:6<875::AID-IJC19>3.0.CO;2-3","volume":"73","author":"T Brodowicz","year":"1997","unstructured":"Brodowicz T, Wiltschke C, Budinsky AC, Krainer M, Steger GG, Zielinski CC: Soluble HER-2\/neu neutralizes biologic effects of anti-HER-2\/neu antibody on breast cancer cells in vitro. Int J Cancer. 1997, 73: 875-879. 10.1002\/(SICI)1097-0215(19971210)73:6<875::AID-IJC19>3.0.CO;2-3.","journal-title":"Int J Cancer"},{"key":"1091_CR136","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/annonc\/mdm585","volume":"19","author":"V Ludovini","year":"2008","unstructured":"Ludovini V, Gori S, Colozza M, Pistola L, Rulli E, Floriani I, Pacifico E, Tofanetti FR, Sidoni A, Basurto C: Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival. Ann Oncol. 2008, 19: 883-890. 10.1093\/annonc\/mdm585.","journal-title":"Ann Oncol"},{"key":"1091_CR137","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s13277-010-0025-9","volume":"31","author":"R Molina","year":"2010","unstructured":"Molina R, Auge JM, Escudero JM, Filella X, Zanon G, Pahisa J, Farrus B, Munoz M, Velasco M: Evaluation of tumor markers (HER-2\/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value. Tumour Biol. 2010, 31: 171-180. 10.1007\/s13277-010-0025-9.","journal-title":"Tumour Biol"},{"key":"1091_CR138","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/172460080401900102","volume":"19","author":"M Saghatchian","year":"2004","unstructured":"Saghatchian M, Guepratte S, Hacene K, Neumann R, Floiras JL, Pichon MF: Serum HER-2 extracellular domain: relationship with clinicobiological presentation and prognostic value before and after primary treatment in 701 breast cancer patients. Int J Biol Markers. 2004, 19: 14-22.","journal-title":"Int J Biol Markers"},{"key":"1091_CR139","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1158\/0008-5472.CAN-11-0241","volume":"71","author":"C Grange","year":"2011","unstructured":"Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, Deregibus MC, Tetta C, Bussolati B, Camussi G: Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 2011, 71: 5346-5356. 10.1158\/0008-5472.CAN-11-0241.","journal-title":"Cancer Res"},{"key":"1091_CR140","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1593\/neo.09822","volume":"11","author":"T Jung","year":"2009","unstructured":"Jung T, Castellana D, Klingbeil P, Cuesta Hernandez I, Vitacolonna M, Orlicky DJ, Roffler SR, Brodt P, Zoller M: CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia. 2009, 11: 1093-1105.","journal-title":"Neoplasia"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-10-134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1479-5876-10-134\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-10-134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T04:46:17Z","timestamp":1714106777000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-10-134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,27]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-10-134","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,27]]},"article-number":"134"}}